Active substance
Clobetasone butyrate
- SFDA 3
- Health Canada 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CLOBESON | 0.05 % | Cream · Topical | 1 Tube | SAR 4.50 | Generic · Prescription | OMAN PHARMACEUTICAL PRODUCTS | Valid |
| CLOBATE 0.05% OINTMENT | 0.05 % | Ointment · Topical | 1 Bottle | SAR 8.30 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Withdrawn by MAH · Not Marketed |
| CORTOFTAL 0.1% OPTH.SUSP | 0.1 % | Eye drops · Ocular use | 1 Dropper Container | SAR 14.45 | NCE · Prescription | ALCON CUSI | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ECZEMA
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| SPECTRO ECZEMACARE MEDICATED CREAM | 02214415 | 0.05 % / W/W | CREAM · TOPICAL | HALEON CANADA ULC |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.